Abstract
Collagen peptides, including glucosamine, are well-known functional food materials that act on bone and cartilage tissues. Collagen peptides are used at a volume of about 6,000 tons per year as a raw material in Japan. Evidence for the action of collagen peptides for both bone and cartilage tissues has accumulated both at basic research level (in vivo and in vitro ) and clinically. To confirm the clinical effect of these peptides and clearly identify their mechanism of action at the molecular level, further clinical studies comprising disease-free subjects, alongside basic research studies, are required.
MeSH terms
-
Animals
-
Bone Density / drug effects
-
Bone and Bones / cytology
-
Bone and Bones / metabolism*
-
Cartilage / cytology
-
Cartilage / metabolism*
-
Cell Differentiation / drug effects
-
Cell Differentiation / genetics
-
Cell Proliferation / drug effects
-
Cell Proliferation / genetics
-
Chondrocytes / cytology
-
Collagen* / chemistry
-
Collagen* / metabolism
-
Collagen* / pharmacology
-
Functional Food*
-
Gene Expression Regulation, Developmental / drug effects
-
Humans
-
Hydroxyproline
-
Osteoblasts / cytology
-
Osteoporosis / metabolism
-
Osteoporosis / prevention & control
-
Peptide Fragments* / chemistry
-
Peptide Fragments* / metabolism
-
Peptide Fragments* / pharmacology
-
Proline
-
Rats
Substances
-
Peptide Fragments
-
Collagen
-
Proline
-
Hydroxyproline